Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUV39H2-DT (SUV39H2 divergent transcript) is a non-coding RNA transcribed divergently from the SUV39H2 locus. Its precise biological function is not currently described, and there are no known therapeutic drugs or disease associations directly related to this RNA. SUV39H2-DT should not be confused with the protein SUV39H2 (Suppressor Of Variegation 3-9 Homolog 2), which is a histone methyltransferase and important drug target in epigenetic therapy and cancer biology[3][9]. All available structured information refers only to the RNA transcript, not the protein.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SUV39H2 divergent transcript (SUV39H2-DT).